The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2
Open accessAbstract
The recombinant human prostaglandin D 2 (PGD 2) receptor, hCRTH2, has been expressed in HEK293(EBNA) and characterized with respect to radioligand binding and signal transduction properties. High and low affinity binding sites for PGD 2 were identified in the CRTH2 receptor population by saturation analysis with respective equilibrium dissociation constants (K D) of 2.5 and 109 n M. This revealed that the affinity of PGD 2 for CRTH2 is eight times less than its affinity for the DP receptor. Equilibrium competition binding assays revealed that of the compounds tested, only PGD 2 and several related metabolites bound with high affinity to CRTH2 (K i values ranging from 2.4 to 34.0 n M) with the following rank order of potency: PGD 2>13,14‐dihydro‐15‐keto PGD 2>15‐deoxy‐Δ 12,14‐PGJ 2>PGJ 2>Δ 12‐PGJ 2>15(S)‐15 methyl‐PGD 2. This is in sharp contrast with the rank order of potency obtained at DP : PGD 2>PGJ 2>Δ 12‐PGJ 2>15‐deoxy‐Δ 12,14‐PGJ 2 >>>13,14‐dihydro‐15‐keto‐PGD 2. Functional studies demonstrated that PGD 2 activation of recombinant CRTH2 results in decrease of intracellular cAMP in a pertussis toxin‐sensitive manner. Therefore, we showed that CRTH2 can functionally couple to the G‐protein G αi/o. PGD 2 and related metabolites were tested and their rank order of potency followed the results of the membrane binding assay. By Northern blot analysis, we showed that, besides haemopoietic cells, CRTH2 is expressed in many other tissues such as brain, heart, thymus, spleen and various tissues of the digestive system. In addition, in situ hybridization studies revealed that CRTH2 mRNA is expressed in human eosinophils. Finally, radioligand binding studies demonstrated that two eosinophilic cell lines, butyric acid‐differentiated HL‐60 and AML 14.3D10, also endogenously express CRTH2. British Journal of Pharmacology (2002) 137, 1163–1172. doi:10.1038/sj.bjp.0704973
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, H., Nakajima, T., Osaka, T., Satoh, S., Kawase, K., Kubo, E., Kantha, S. S., Kasahara, K., & Hayaishi, O. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.11998 · Cited by 143
Cited by
Hata, A. N., & Breyer, R. M. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.06.003 · Cited by 840
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology
Buczynski, M. W., Dumlao, D. S., & Dennis, E. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900004-jlr200 · Cited by 530
Woodward, D. F., Jones, R. L., & Narumiya, S. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003517 · Cited by 443
Prostanoids and prostanoid receptors in signal transduction
Bos, C. L., Richel, D. J., Ritsema, T., Peppelenbosch, M. P., & Versteeg, H. H. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2003.08.006 · Cited by 387
Metadata
- Authors
- Sawyer, N., Cauchon, E., Chateauneuf, A., Cruz, R. P. G., Nicholson, D. W., Metters, K. M., O'Neill, G. P., & Gervais, F. G.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2002-12
- Volume
- 137
- Issue
- 8
- Pages
- 1163-1172
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2073651858
- Cited by
- 194
- References
- 1
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2. https://app.cochat.ai/papers/10.1038/sj.bjp.0704973
- The paper
- Sawyer, N., Cauchon, E., Chateauneuf, A., Cruz, R. P. G., Nicholson, D. W., Metters, K. M., O'Neill, G. P., & Gervais, F. G. (2002). Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0704973
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.